Neutral
CVS Health Corp's shares surged 3.2% to $78.86, with a GF Score of 83/100, indicating strong fundamentals but moderate financial stability. The stock ...
Bearish
The Tennessee House passed a bill, the Fair RX Act, that would ban pharmacies from owning Pharmacy Benefits Managers (PBMs), sending it to Gov. Bill L...
Neutral
CVS Health Corp (CVS) shares recently fell 3.4% to $74.99 and are considered undervalued by 5.0% according to GuruFocus' GF Value™ of $78.91. Despite ...
Neutral
CVS Health's integrated model, combining retail pharmacies, pharmacy benefits management (Caremark), and health insurance (Aetna), positions it as a d...
Neutral
UBS analyst Kevin Caliendo reiterated a Buy rating and $97 price target on CVS Health Corporation (NYSE:CVS), citing the potential for a proposed sett...
Neutral
The Trump administration admitted to using incorrect figures to initiate a Medicaid fraud investigation in New York, raising concerns about the basis ...
Neutral
CVS Health (NYSE: CVS) announced it will hold its first-quarter 2026 earnings conference call on Wednesday, May 6, 2026, at 8:00 a.m. ET. An audio web...